For purpose of this Article 48, the following terms have the following meanings:
“City” means the City and County of San Francisco.
“Department” means the San Francisco Department of Public Health.
“Director” means the Director of the San Francisco Department of Public Health or the Director’s designee.
“FDA” means the United States Food and Drug Administration.
“Opioid Antagonist” means Naloxone nasal spray (NARCAN®) or any other formulation of naloxone hydrochloride or similar drug approved or authorized by the FDA for the treatment of an opioid overdose.
“Pharmacist” means an individual licensed by the California State Board of Pharmacy to engage in the practice of pharmacy.
“Retail Pharmacy” means a licensed pharmacy, as defined in subdivision (a) of Section 4037 of the California Business and Professions Code, that is located in the City and dispenses drugs for retail sale.
(Added by Ord. 219-23, File No. 230766, App. 11/3/2023, Eff. 12/4/2023)